Human SST(Somatostatin) ELISA Kit – ATO4807
ATO4807
Size:Price:
48 T$320.00
96 T$458.00
Download

Overview

Product name: Human SST(Somatostatin) ELISA Kit
Reactivity: Human
Alternative Names: GHIH; SRIF; SMST; GHRIH; GHRIF; Growth Hormone Releasing Inhibiting Hormone; Somatotropin Release-Inhibiting Factor; Somatostatin-14; Somatostatin-28
Assay Type: Competitive Inhibition
Sensitivity: 2.62 pg/mL
Standard: 500 pg/mL
Detection Range: 7.82-500 pg/mL
Sample Type: Serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
Assay Length: 2h
Research Area: Tumor immunity;Endocrinology;Hormone metabolism;
Uniprot ID: P61278
Test principle: This assay employs the competitive inhibition enzyme immunoassay technique. The microtiter plate provided in this kit has been pre-coated with Human SST protein. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human SST. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm 10nm. The concentration of Human SST in the samples is then determined by comparing the OD of the samples to the standard curve.

Standard curve

Concentration (pg/mL) OD Corrected OD
500.00 0.189
250.00 0.397
125.00 0.611
62.50 0.812
31.25 1.112
15.63 1.592
7.82 1.715
0.00 2.213

Precision

Intra-assay Precision (Precision within an assay):CV%<8%

Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.

Inter-assay Precision (Precision between assays):CV%<10%

Three samples of known concentration were tested in forty separate assays to assess inter-assay precision.

Recovery

Matrices listed below were spiked with certain level of recombinant SST and the recovery rates were calculated by comparing the measured value to the expected amount of SST in samples.
Matrix Recovery range Average
serum(n=5) 87-97% 90%
EDTA plasma(n=5) 81-95% 88%
Heparin plasma(n=5) 83-95% 88%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of SST and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Matrix 1:2 1:4 1:8 1:16
serum(n=5) 85-97% 86-102% 89-102% 85-98%
EDTA plasma(n=5) 83-103% 82-93% 86-95% 81-96%
Heparin plasma(n=5) 96-105% 83-101% 87-98% 95-102%